| front |
back |
revisions |
lasted changed by |
history |
| Tachyarrhythmias Ventricular |
Premature ventricular contraction (PVC)
Ventricular tachycardia/fibrillation
Torsades de pointes |
0 |
ladyer86 Wed, 08 Feb 2012 04:16:36 GMT |
 |
Tachyarrhythmias
Supraventricular |
Premature atrial contraction (PAC)
Artial fibrillation/flutter
Multifocal atrial tachycardia (MAT)
Paroxysmal supraventricular tachycardia (PSVT)
Wolff-Parkinson-White syndrome (WPW) |
0 |
ladyer86 Wed, 08 Feb 2012 04:16:36 GMT |
|
| Bradyarrhythmias |
Sinus node dysfunction
Atrioventricular block |
0 |
ladyer86 Wed, 08 Feb 2012 04:16:36 GMT |
|
| What drug category is Carvediolol in? |
vasodilator AND B-blocker |
0 |
ladyer86 Tue, 07 Feb 2012 02:55:41 GMT |
|
| Carvediolol target dose |
25 mg bid; 50 mg bid (> 85 kg |
0 |
ladyer86 Tue, 07 Feb 2012 02:55:41 GMT |
|
| Carvediolol initial dose |
3.125 mg bid |
0 |
ladyer86 Tue, 07 Feb 2012 02:55:41 GMT |
|
| Adverse Effects of ACE inhibitors |
Hypotension
K+ increase
Cough
Renal Insufficiency
Angioedema |
0 |
ladyer86 Tue, 07 Feb 2012 02:55:40 GMT |
|
| What kind of patients is fosinopril especially good for? |
renal |
0 |
ladyer86 Tue, 07 Feb 2012 02:55:40 GMT |
|
| target dose for lisinopril |
20-40 mg qd |
0 |
ladyer86 Tue, 07 Feb 2012 02:55:40 GMT |
|
| initial dose for lisinopril |
2.5-5 mg qd |
0 |
ladyer86 Tue, 07 Feb 2012 02:55:40 GMT |
|
| target dose for fosinopril |
40 mg qd |
0 |
ladyer86 Tue, 07 Feb 2012 02:55:40 GMT |
|
| Initial dose for fosinopril |
5-10 mg qd |
0 |
ladyer86 Tue, 07 Feb 2012 02:55:40 GMT |
|
| Dietary modifications for refractory patients |
Sodium (max 2 gm per day; normal 3 to 6 gm per day)
Fluids: 2 liters per day if needed |
0 |
ladyer86 Tue, 07 Feb 2012 02:55:40 GMT |
|
| NYHA Functional Class IV |
Symptomatic at rest resulting in inability to carry on any physical activity without discomfort (severe HF) |
0 |
ladyer86 Tue, 07 Feb 2012 02:29:26 GMT |
|
| NYHA Functional Class III |
Symptomatic with minimal exertion resulting in marked limitations of PA (moderate HF) |
0 |
ladyer86 Tue, 07 Feb 2012 02:29:26 GMT |
|
| NYHA Functional Class II |
Symptomatic with moderate exertion resulting in slight limitation of PA (mild HF) |
0 |
ladyer86 Tue, 07 Feb 2012 02:29:26 GMT |
|
| NYHA Functional Class I |
Cardiac disease, asymptomatic and without limitations of PA |
0 |
ladyer86 Tue, 07 Feb 2012 02:29:26 GMT |
|
| ACC/AHA Heart Failure Stage D |
End stage HF requiring specialized intervention |
0 |
ladyer86 Tue, 07 Feb 2012 02:28:18 GMT |
|
| ACC/AHA Heart Failure Stage C |
Current or previous symptoms of HF, with structural disease |
0 |
ladyer86 Tue, 07 Feb 2012 02:28:18 GMT |
|
| ACC/AHA Heart Failure Stage B |
Structural heart but no symptoms of HF (low EF, but no sx) |
0 |
ladyer86 Tue, 07 Feb 2012 02:28:18 GMT |
|
| ACC/AHA Heart Failure Stage A |
High risk for developing HF but no structural heart disease |
0 |
ladyer86 Tue, 07 Feb 2012 02:27:07 GMT |
|
| Compensatory Response to (early) HF |
Ventricular hypertrophy and remodeling
Vasoconstriction
Tachycardia and increased contractility
˄Preload |
0 |
ladyer86 Tue, 07 Feb 2012 02:27:07 GMT |
|
| Major players in accelerating HF |
norepinephrine and angiotensin II |
0 |
ladyer86 Tue, 07 Feb 2012 02:27:07 GMT |
|
| primary cause of heart failure |
History of HTN |
0 |
ladyer86 Tue, 07 Feb 2012 02:27:07 GMT |
|
